APA (7th ed.) Citation

Heinke, A., Warter, A., Nagel, I. D., Agnihotri, A., Mehta, N. N., Galang, C. M. B., . . . Freeman, W. R. Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): Seven-months results using artificial intelligence and OCTA. BMC.

Chicago Style (17th ed.) Citation

Heinke, Anna, et al. Faricimab for Treatment-resistant Choroidal Neovascularization (CNV) in Neovascular Age-related Macular Degeneration (nAMD): Seven-months Results Using Artificial Intelligence and OCTA. BMC.

MLA (9th ed.) Citation

Heinke, Anna, et al. Faricimab for Treatment-resistant Choroidal Neovascularization (CNV) in Neovascular Age-related Macular Degeneration (nAMD): Seven-months Results Using Artificial Intelligence and OCTA. BMC.